ArticleClinical pharmacology and therapeutics2013
Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine.
Abstract read
In one paragraph
Article in Clinical pharmacology and therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- The Implementation of Pharmacogenetics in the United Kingdom.Handbook of experimental pharmacology · 2023Article
- Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review.Frontiers in medicine · 2022Article
- Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program.Journal of personalized medicine · 2021Article
- Methods and implementation of a pediatric asthma pharmacogenomic study in the emergency department setting.Pharmacogenetics and genomics · 2020Article
- Pharmacogenomics in Practice.Clinical pharmacology and therapeutics · 2019Article
- Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2019Article
- Current landscape of personalized medicine adoption and implementation in Southeast Asia.BMC medical genomics · 2018Article
- The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.Clinical pharmacology and therapeutics · 2017Article
- Multidisciplinary model to implement pharmacogenomics at the point of care.Genetics in medicine : official journal of the American College of Medical Genetics · 2017Article
- Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2017Article
- Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature.BMJ open · 2016Article
- Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.The Journal of molecular diagnostics : JMD · 2016Article
- CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.Journal of the American Medical Informatics Association : JAMIA · 2015Article
- An inter-professional approach to personalized medicine education: one institution's experience.Personalized medicine · 2015Article
- EHR based Genetic Testing Knowledge Base (iGTKB) Development.BMC medical informatics and decision making · 2015Article
- Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.Annual review of pharmacology and toxicology · 2015Review
- Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.Clinical pharmacology and therapeutics · 2014Article
- Biobanks and personalized medicine.Clinical genetics · 2014Review
- Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.American journal of medical genetics. Part C, Seminars in medical genetics · 2014Article
- Clinical pharmacogenetics implementation: approaches, successes, and challenges.American journal of medical genetics. Part C, Seminars in medical genetics · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
G FarrugiaDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
R M Weinshilboum
Funding
Physiological Characterization and Data Integration CoreP01DK068055 · NIDDK · MAYO CLINIC ROCHESTER · PI ORDOG, TAMAS · 2004 to 2019
$23.8MGastroparesis Consortium Continuation-Data Coordinating CenterU01DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2006 to 2015
$17.4MPharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8MMECHANOTRANSDUCTION IN INTESTINAL SMOOTH MUSCLE CELLSR01DK052766 · NIDDK · MAYO CLINIC ROCHESTER · PI BEYDER, ARTHUR, FARRUGIA, GIANRICO · 1997 to 2025
$8.3MCALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJALR01DK057061 · NIDDK · MAYO CLINIC ROCHESTER · PI GIANRICO FARRUGIA, Tamas Ordog · 2000 to 2026
$8.2MINHERITED VARIATIONS IN DRUG-METABOLIZING ENZYMESR01GM028157 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 1985 to 2019
$6.9MThe GpCRC Pediatric Gastroparesis Registry 2 (PGpR2): Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants with Symptoms of GastU01DK074035 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Irene Sarosiek · 2008 to 2026
$6.7MPharmacogenomics of Breast Cancer Adjuvant ChemotherapyU01HG005137 · NHGRI · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2009 to 2011
$2.1MPharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemiaR01CA132780 · NCI · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2008 to 2013
$1.6MNCI NIH HHS R01 CA132780NHGRI NIH HHS U01 HG005137NIDDK NIH HHS P01 DK068055NIDDK NIH HHS P01 DK68055NIDDK NIH HHS R01 DK052766NIDDK NIH HHS R01 DK057061NIDDK NIH HHS R01 DK52766NIDDK NIH HHS R01 DK57061NIDDK NIH HHS U01 DK074008NIDDK NIH HHS U01 DK074035NIDDK NIH HHS U01 DK74008NIGMS NIH HHS R01 GM028157NIGMS NIH HHS R01 GM28157NIGMS NIH HHS U19 GM061388NIGMS NIH HHS U19 GM61388
Abstract
PubMed holds no abstract for this paper.
Indexed as
Academic Medical CentersBiomarkersElectronic Health RecordsGenomicsHumansPharmacogeneticsPrecision MedicineBiomarkers
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.